RETRACTED ARTICLE: MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel

Jie Yan, Litong Shi, Shan Lin, Yi Li

Open source

DOI
10.1080/21655979.2021.1938497
Published
2021-01
Container
Bioengineered
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/21655979.2021.1938497,
  title = {RETRACTED ARTICLE: MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel},
  author = {Jie Yan and Litong Shi and Shan Lin and Yi Li},
  year = {2021},
  journal = {Bioengineered},
  doi = {10.1080/21655979.2021.1938497},
  url = {https://doi.org/10.1080/21655979.2021.1938497}
}

RIS

TY  - JOUR
TI  - RETRACTED ARTICLE: MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel
AU  - Jie Yan
AU  - Litong Shi
AU  - Shan Lin
AU  - Yi Li
PY  - 2021
JO  - Bioengineered
DO  - 10.1080/21655979.2021.1938497
UR  - https://doi.org/10.1080/21655979.2021.1938497
ER  - 

APA

Yan, J., Shi, L., Lin, S., & Li, Y. (2021). RETRACTED ARTICLE: MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel. Bioengineered. https://doi.org/10.1080/21655979.2021.1938497

Source records